Cargando…
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
PURPOSE: Bariatric surgery, as Roux-en-Y gastric bypass (RYGB), laparoscopic gastric banding (LGB), and laparoscopic sleeve gastrectomy (LSG), is considered the gold standard treatment to achieve long-term weight loss in severe obesity. In patients who fail to maintain the achieved weight, pharmacol...
Autores principales: | Muratori, Fabrizio, Vignati, F., Di Sacco, G., Gavazzi, L., Pellegrino, D., Del Prete, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556416/ https://www.ncbi.nlm.nih.gov/pubmed/35763245 http://dx.doi.org/10.1007/s40519-022-01403-9 |
Ejemplares similares
-
Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post‐bariatric surgery
por: Wharton, Sean, et al.
Publicado: (2019) -
Exposure–response analyses of liraglutide 3.0 mg for weight management
por: Wilding, J. P. H., et al.
Publicado: (2016) -
Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers
por: Fujioka, Ken, et al.
Publicado: (2016) -
Weight Regain after Bariatric Surgery
por: Ribeiro-Parenti, Lara, et al.
Publicado: (2023) -
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
por: Overgaard, Rune V., et al.
Publicado: (2016)